Latest News

QIAGEN: Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase




VENLO, Netherlands–(BUSINESS WIRE)–QIAGEN N.V. announces that it will initiate the repurchase of a fourth tranche of shares under the share repurchase program which was announced by an ad hoc announcement dated January 31, 2018. In the time period between May 10, 2019 until June 18, 2019, at the latest, a fourth tranche of up to 2 million common shares of the Company having a total purchase price of up to USD 50 million (or the equivalent Euro amount thereof, in each case without ancillary pu

Source link




Related posts

Is Talc Powder Safe? What To Know About Potential Cancer Risks

Newsemia

System Makes Legs Same Length Following Hip Replacement

Newsemia

Readmissions reduction program may be associated with increase in patient-level mortality

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy